Skip to main content
AstraZeneca Pharma India Ltd. logo

AstraZeneca Pharma India Ltd. — Investor Relations & Filings

Ticker · ASTRAZEN ISIN · INE203A01020 LEI · 335800N8M7W5JDTAHR68 BSE.NS Manufacturing
Open in API
Filings indexed 1,263 across all filing types
Latest filing 2022-03-16 Regulatory Filings
Country IN India
Listing BSE.NS ASTRAZEN

About AstraZeneca Pharma India Ltd.

https://www.astrazeneca.com/content/az-…

AstraZeneca Pharma India Ltd. is a science-led biopharmaceutical organization dedicated to the discovery, development, and commercialization of innovative prescription medicines. The company focuses on core therapeutic areas including Oncology, Cardiovascular, Renal & Metabolism, Respiratory & Immunology, and Rare Disease. Its product portfolio includes advanced treatments such as Tagrisso, Lynparza, and Imfinzi for various cancers, as well as Forxiga and Brilinta for metabolic and cardiovascular conditions. The company utilizes a robust global research pipeline to address complex medical challenges and improve patient outcomes. Through clinical research and specialized healthcare solutions, it delivers transformative therapies designed to treat chronic and life-threatening diseases. The organization is characterized by its commitment to scientific excellence and the delivery of high-value medical interventions.

Recent filings

Filing Released Lang Actions
Closure of trading window
Regulatory Filings Classification · 95% confidence The document is a short notice informing stock exchanges about the closure of the trading window in compliance with insider trading regulations. It references the upcoming declaration of audited financial results but does not contain any financial data or the results themselves. The length is only 1205 characters, indicating it is a brief announcement rather than a full report. Therefore, it is neither an Annual Report, Audit Report, nor Earnings Release. It is also not a certification or a voting result. The content fits best as a Regulatory Filing (RNS) since it is a compliance-related announcement that does not fit other specific categories.
2022-03-16 English
This is to inform you that, in accordance with the provisions of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, the Trading Window for dealing ....
Regulatory Filings Classification · 95% confidence The document is a short notice informing stock exchanges about the closure of the trading window in compliance with insider trading regulations. It references the upcoming declaration of audited financial results but does not contain any financial data or the results themselves. The length is only 1205 characters, indicating it is a brief announcement rather than a full report. Therefore, it is not an Annual Report, Audit Report, or Earnings Release. It is also not a certification or legal proceeding update. The content fits best as a Regulatory Filing (RNS) since it is a compliance-related announcement to the stock exchanges without substantive financial data or detailed report content.
2022-03-16 English
General updates
Regulatory Filings Classification · 95% confidence The document is a certificate pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, issued by the Registrar and Transfer Agent confirming compliance with dematerialization regulations for the period 01.01.2022 to 28.02.2022. It is addressed to stock exchanges and signed by the company secretary. The document is short (3266 characters) and primarily serves as a compliance certificate rather than a financial report or announcement of financial results. It does not contain financial statements, management discussion, or detailed financial data. It is a regulatory compliance certificate related to securities dematerialization and transfer agent activities. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory compliance documents that do not fit other specific categories.
2022-03-11 English
We are enclosing herewith Certificate dated March 5, 2022 issued by Integrated Registry Management Services Private Limited, Registrar and Transfer Agents (RTA) of the Company confirming ....
Regulatory Filings Classification · 95% confidence The document is a certificate pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, issued by the Registrar and Transfer Agent confirming compliance with dematerialization regulations for the period 01.01.2022 to 28.02.2022. It is addressed to stock exchanges and signed by the company secretary. The document is short (3266 characters) and primarily serves as a compliance certificate rather than a financial report or announcement of financial results. It does not contain financial statements, management discussion, or other report content. It is a regulatory compliance filing related to securities dematerialization and transfer agent confirmation. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements and certifications that do not fit other specific categories.
2022-03-11 English
Newspaper Advertisements
Regulatory Filings
2022-02-25 English
Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing a copy of newspaper advertisement published in Business Standard ....
Regulatory Filings
2022-02-25 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.